In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and ...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...